MDLN
Medline Inc. NASDAQ Listed Dec 17, 2025$34.32
-0.55%
vs $34.51
Mkt Cap $29.0B
52w Low $32.81
8.3% of range
52w High $50.88
50d MA $38.05
200d MA $41.90
P/E (TTM)
30.3x
EV/EBITDA
14.1x
P/B
1.4x
Debt/Equity
1.2x
ROE
-0.1%
P/FCF
16.0x
RSI (14)
35.50
ATR (14)
$1.68
Beta
1.98
50d MA
$38.05
200d MA
$41.90
Avg Volume
7.5M
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
3 Lakes Drive · Northfield, IL 60093 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | BMO | 0.33 | 0.50 | +51.7% | 42.04 | -11.3% | -12.8% | -5.9% | — | — | — | — |
| May 6, 2026 | BMO | 0.30 | 0.33 | +11.8% | 45.32 | -5.0% | -7.3% | -0.4% | -5.6% | -0.7% | -1.8% | — |
| Feb 25, 2026 | BMO | 0.24 | 0.22 | -5.6% | 48.18 | +2.5% | +1.5% | -2.8% | -3.5% | -3.2% | -3.4% | — |
| Nov 4, 2025 | BMO | — | 0.31 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | JP Morgan | Maintains | Overweight → Overweight | — | $43.41 | $43.53 | +0.3% | -1.2% | -1.1% | -3.1% | +0.9% | +0.7% |
| Mar 9 | BTIG | Maintains | Buy → Buy | — | $43.83 | $43.10 | -1.7% | -1.0% | -1.2% | -1.1% | -3.1% | +0.9% |
| Mar 9 | Tigress Financial | Maintains | Buy → Buy | — | $43.83 | $43.10 | -1.7% | -1.0% | -1.2% | -1.1% | -3.1% | +0.9% |
| Mar 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $47.51 | $47.14 | -0.8% | -3.5% | -3.2% | -3.4% | +2.7% | -0.5% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $48.89 | $49.09 | +0.4% | -2.8% | -3.5% | -3.2% | -3.4% | +2.7% |
| Feb 26 | BMO Capital | Maintains | Outperform → Outperform | — | $48.18 | $49.38 | +2.5% | +1.5% | -2.8% | -3.5% | -3.2% | -3.4% |
| Feb 26 | Citigroup | Maintains | Buy → Buy | — | $48.18 | $49.38 | +2.5% | +1.5% | -2.8% | -3.5% | -3.2% | -3.4% |
| Feb 26 | Evercore ISI | Maintains | Outperform → Outperform | — | $48.18 | $49.38 | +2.5% | +1.5% | -2.8% | -3.5% | -3.2% | -3.4% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $48.18 | $49.38 | +2.5% | +1.5% | -2.8% | -3.5% | -3.2% | -3.4% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $48.18 | $49.38 | +2.5% | +1.5% | -2.8% | -3.5% | -3.2% | -3.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Golwas Douglas P | Chief Commercial Officer | Sell | 38,034 | $37.05 | $1.4M | 23,899 | -1.32% | +4.77% |
| Jun 16, 2026 | Golwas Douglas P | Chief Commercial Officer | Sell | 61,966 | $36.60 | $2.3M | 61,933 | -1.32% | +4.77% |
| Jun 5, 2026 | CORCORAN JESSI L | Principal Accounting Officer | Buy | 5,000 | $34.15 | $171K | 5,000 | +1.47% | -0.64% |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — | Sell | 1,262,726 | $36.54 | $46.1M | 6,519,062 | -7.16% | +0.57% |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — | Sell | 11,904,646 | $36.54 | $435.0M | 62,591,526 | -7.16% | +0.57% |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — | Sell | 753,528 | $36.54 | $27.5M | 3,422,699 | -7.16% | +0.57% |
| May 28, 2026 | Hellman & Friedman Capital Partners X (Parallel), L.P. | — | Sell | 17,947,337 | $36.54 | $655.8M | 228,840 | -7.16% | +0.57% |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. | — | Sell | 1,489,924 | $36.54 | $54.4M | 1,539 | -7.16% | +0.57% |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. | — | Sell | 2,256,800 | $36.54 | $82.5M | 10,250,904 | -7.16% | +0.57% |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. | — | Sell | 9,858,774 | $36.54 | $360.2M | 10,185 | -7.16% | +0.57% |
| May 28, 2026 | BX Mozart ML-2 Holdco L.P. | — | Sell | 19,712,326 | $36.54 | $720.2M | 89,537,913 | -7.16% | +0.57% |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. | — | Sell | 1,489,924 | $36.54 | $54.4M | 1,539 | -7.16% | +0.57% |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. | — | Sell | 2,256,800 | $36.54 | $82.5M | 10,250,904 | -7.16% | +0.57% |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. | — | Sell | 9,858,774 | $36.54 | $360.2M | 10,185 | -7.16% | +0.57% |
| May 28, 2026 | BCP 8 Holdings Mozart Manager L.L.C. | — | Sell | 19,712,326 | $36.54 | $720.2M | 89,537,913 | -7.16% | +0.57% |
8-K · 2.02
!! High
Medline Inc. -- 8-K 2.02: Earnings Results
Medline Inc. released second quarter and first-half 2026 earnings results, providing investors with updates on operational performance and financial condition for the period ending June 27, 2026.
Aug 5
8-K
Medline Inc. -- 8-K Filing
Jun 12
8-K
Medline Inc. -- 8-K Filing
Jun 2
8-K · 2.02
!! High
Medline Inc. -- 8-K 2.02: Earnings Results
Medline reported Q1 2026 earnings results, allowing investors to assess the company's operational performance and financial health during the quarter.
May 6
8-K
Medline Inc. -- 8-K Filing
Medline's public offering comes as the company reports strong 2025 revenue growth of 11.5% to $28.4 billion, though net income declined 3.6%, signaling profitability pressure despite solid top-line expansion.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 36,556,201 | $1.6B | Added | Mar 2026 |
| 2 | Morgan Stanley | 30,324,120 | $1.3B | New | Dec 2025 |
| 3 | Capital Research Global Investors | 23,161,670 | $1.0B | Added | Mar 2026 |
| 4 | Invesco Ltd. | 20,963,615 | $933M | Added | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 14,729,681 | $655M | New | Mar 2026 |
| 6 | Vanguard Portfolio Management Llc | 14,150,752 | $630M | New | Mar 2026 |
| 7 | Lone Pine Capital Llc | 11,789,156 | $525M | New | Mar 2026 |
| 8 | Viking Global Investors | 11,433,992 | $509M | Added | Mar 2026 |
| 9 | Janus Henderson Group Plc | 11,451,861 | $507M | New | Mar 2026 |
| 10 | Durable Capital Partners Lp | 7,265,853 | $323M | Added | Mar 2026 |
| 11 | Artisan Partners Limited Partnership | 6,629,443 | $295M | Added | Mar 2026 |
| 12 | Healthcare Of Ontario Pension Plan Trust Fund | 5,000,000 | $222M | Added | Mar 2026 |
| 13 | Capital World Investors | 4,311,124 | $192M | Added | Mar 2026 |
| 14 | Point72 Asset Management | 3,304,305 | $147M | Added | Mar 2026 |
| 15 | Ubs Group Ag | 3,191,661 | $142M | Added | Mar 2026 |
| 16 | Alyeska Investment Group, L.p. | 2,937,389 | $131M | Added | Mar 2026 |
| 17 | Bank Of America Corp /de/ | 2,288,251 | $102M | New | Mar 2026 |
| 18 | Millennium Management | 1,955,949 | $87M | Added | Mar 2026 |
| 19 | Citadel Advisors Llc | 1,593,358 | $71M | Reduced | Mar 2026 |
| 20 | Jpmorgan Chase & Co | 1,470,444 | $63M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$29.02B
Enterprise Value
$38.57B
P/E (TTM)
30.27x
Forward P/E
23.44x
PEG Ratio
-4.97x
P/B
1.44x
P/S
0.96x
P/FCF
15.98x
EV/EBITDA
14.12x
Shares Out
812.0M
Financials (TTM)
Revenue
$29.14B
Net Income
$964.0M
EBITDA
$2.73B
Free Cash Flow
$1.74B
Op Cash Flow
$1.74B
EPS Basic
$1.43
EPS Diluted
$1.21
EPS Forward
$1.46
Gross Margin
24.0%
Op Margin
7.0%
Net Margin
3.3%
Balance Sheet
Total Assets
$38.48B
Total Liab.
$19.20B
Total Equity
$19.29B
Cash
$1.94B
LT Debt
$12.48B
Book Value/Sh
$23.75
Debt/Equity
1.17x
Current Ratio
4.29
Quick Ratio
2.37
Returns & Growth
ROE
-0.1%
ROA
-0.0%
ROIC
5.7%
Rev Growth YoY
+11.5%
EPS Growth YoY
-5.9%
Price Returns
2W
-8.3%
1M
-19.8%
3M
-17.6%
6M
-27.0%
12M
-15.8%
Technicals
52W High
$50.88
52W Low
$32.81
50d MA
$38.05
200d MA
$41.90
RSI (14)
35.50
ATR (14)
$1.68
Beta
1.98
Avg Volume
7.5M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$48.82
High
$60.00
Low
$38.00
Median
$48.50
Data updated apr 26, 2026 11:41am
· Source: financialmodelingprep.com